Board Meeting18 May 2026, 04:41 pm
Natco Pharma Board Meeting on May 29, 2026
AI Summary
Natco Pharma Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities will be closed from May 19, 2026, until 48 hours after the declaration of financial results, as per SEBI regulations.
Key Highlights
- Natco Pharma's board will meet on May 29, 2026, to approve audited financial results.
- The meeting will cover results for the quarter and year ending March 31, 2026.
- Trading window closure starts May 19, 2026, lasting until 48 hours post-results.
- The closure complies with SEBI's Insider Trading Regulations, 2015.
Price Impact
More from NATCOPHARM
More in Board Meeting